Furthermore, ZNF532 was mainly distributed in cluster 6, and COLEC12 was mainly distributed in cluster 5 (Figure 9(g)), which that suggested cluster 6 and cluster 5 in fibroblasts were mainly involved in tumor progression and immunotherapy of CRC. Here, ZNF532 is linked to neoplasm.